パートナー

ThinkCyte’s partnering program is designed to help accelerate research and development of novel therapeutics and artificial intelligence (AI)-based approaches in life science.
Image of business people shaking hands.

シンクサイトでは、3つの異なる領域で、パートナーとの提携の拡大・強化を図っています。具体的な提携領域は、疾患プロファイリング分野、バイオ製薬分野、AI分野の3つです。これら戦略的プラットフォームでの提携の強化や共同研究の実施を通じ、ヘルスケア分野において新たな知見を広げることを目指しています。

Disease Profiling Platform

  • Biomarker development for diagnostics applications including LDT, IVD, and CDx products
  • Out-licensing for instrument development, including clinical grade point-of-care devices
  • System integration into CLIA labs for advanced diagnostics services with improved workflows

AI Platform

  • Co-development of morphometric database with functional, clinical, and / or meta-omic annotations
  • Co-development and validation of novel drug target identification workflows to shorten time-to-clinic
  • Data-mining of morphometric inputs to discover novel drug targets

biopharma platform

  • Co-development of label-free approaches for cell therapy R&D
  • Co-development of drug screening platforms based to improve discovery efforts
  • Co-development of morphometric workflows to discover unique cell subpopulations for cell line development

Interested in partnering with ThinkCyte?